Perhaps. A new study in Science suggests a very high prevalence of the Epstein-Barr virus in patients with Multiple Sclerosis (MS). This strong evidence may aid those suffering from MS and give us all a better sense of how endemic infections may have long-term consequences that we are slow to recognize because of the long delay between infection and symptoms.
